Start with a lower dose of valsartan for elderly patients, typically 40mg once daily. Carefully monitor for hypotension, especially during initial treatment and dose adjustments. This is particularly important due to age-related changes in kidney and liver function.
Regularly assess kidney function with serum creatinine tests. Reduce the dose or discontinue valsartan if creatinine clearance significantly declines. This helps prevent drug accumulation and minimizes the risk of adverse events.
Be aware of potential drug interactions. Many elderly patients take multiple medications; review all medications for potential interactions with valsartan. Adjust dosages as needed to mitigate these risks.
Monitor for signs of hyperkalemia, especially in patients with impaired renal function or those taking potassium-sparing diuretics. Regular blood tests can detect this electrolyte imbalance early.
Observe the patient for signs and symptoms of orthostatic hypotension, such as dizziness or fainting upon standing. This is common in the elderly and can be exacerbated by valsartan. Consider dosage adjustments or alternative medication if this occurs.
Consult geriatric guidelines and clinical practice recommendations before prescribing valsartan for elderly individuals. This provides additional support and best-practice advice.
Always prioritize patient safety and individualize treatment based on the patient’s specific health status and response to therapy.
